Aethlon Medical (AEMD) Shareholder's Equity Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.10% |
| Sep 30, 2025 | -15.79% |
| Jun 30, 2025 | -25.77% |
| Mar 31, 2025 | -11.20% |
| Dec 31, 2024 | 2.64% |
| Sep 30, 2024 | 211.05% |
| Jun 30, 2024 | 53.63% |
| Mar 31, 2024 | 20.19% |
| Dec 31, 2023 | 19.15% |
| Sep 30, 2023 | 20.80% |
| Jun 30, 2023 | 20.73% |
| Mar 31, 2023 | 20.08% |
| Dec 31, 2022 | 30.28% |
| Sep 30, 2022 | 299.76% |
| Jun 30, 2022 | 80.66% |
| Mar 31, 2022 | 95.47% |
| Dec 31, 2021 | 207.71% |
| Sep 30, 2021 | 180.51% |
| Jun 30, 2021 | 124.54% |
| Mar 31, 2021 | 43.97% |
| Dec 31, 2020 | 33.38% |
| Sep 30, 2020 | 28.31% |
| Jun 30, 2020 | 24.51% |
| Mar 31, 2020 | 70.11% |
| Dec 31, 2019 | 24.06% |
| Sep 30, 2019 | 14.94% |
| Jun 30, 2019 | 17.88% |
| Mar 31, 2019 | 16.61% |
| Dec 31, 2018 | 18.06% |
| Sep 30, 2018 | 18.61% |
| Jun 30, 2018 | 20.87% |
| Mar 31, 2018 | 21.61% |
| Dec 31, 2017 | 21.33% |
| Sep 30, 2017 | 14.90% |
| Jun 30, 2017 | 36.51% |
| Mar 31, 2017 | 15.60% |
| Dec 31, 2016 | 15.01% |
| Sep 30, 2016 | 53.80% |
| Jun 30, 2016 | 15.60% |
| Mar 31, 2016 | 17.62% |